From 2016-23, Itad evaluated the Fleming Fund’s portfolio of country and regional grants, global projects and fellowship schemes – all of which sought to strengthen AMR surveillance systems.
Read: stories of national progress on AMR in Africa and Asia
AMR is an insidious and cripplingly inequitable pandemic, but it doesn’t make the headlines in the same way that COVID-19 does. Yet, millions of lives are claimed yearly, including mothers and children. AMR is a deeply painful and personal crisis, and a global emergency facing hospitals and community health centres, farms, and even seeping into the soil and rivers around us.
AMR surveillance systems are crucial for identifying the scale of resistance across the animal and human health sectors and developing suitable interventions for optimising antimicrobial use.
This report presents stories of change from Malawi, Nepal, Timor-Leste and Kenya, to illustrate some of the tangible differences taking place in countries supported by the Fleming Fund.
By showcasing these achievements, we aim to not only celebrate progress, but also to inspire further action and commitment to tackling AMR globally.
Read and download the report on the Fleming Fund website.
About the Fleming Fund
The Fleming Fund is a UK aid programme supporting up to 25 countries across Africa and Asia to tackle antimicrobial resistance (AMR). The Fund is led by the UK Department of Health and Social Care (DHSC) and the grants programme managed by Mott MacDonald. The Fleming Fund invests in strengthening surveillance systems through a portfolio of grants, global projects and fellowships.
